Medical Importance of Sex Hormone Binding Globulin (SHBG)
Sex Hormone Binding Globulin (SHBG) is a critical biomarker in clinical medicine that serves as an important indicator of various endocrine, metabolic, and reproductive disorders, with its levels directly impacting morbidity and mortality through its regulation of sex hormone bioavailability.
Primary Functions of SHBG
SHBG is a glycoprotein with several key physiological roles:
- Transport function: Binds and transports sex steroids (primarily testosterone and estradiol) in plasma with high affinity and specificity 1, 2
- Hormone bioavailability regulation: Controls the distribution between protein-bound and free (bioactive) sex hormones 2
- Cell signaling: Participates in a novel steroid-signaling system at the cell membrane via cAMP, independent of classical intracellular steroid receptors 3
Sites of Production
- Primary site: Liver (main peripheral source) 1
- Secondary sites:
Clinical Significance as a Biomarker
SHBG serves as an important marker in several clinical conditions:
1. Metabolic Disorders
- Insulin resistance: Associated with low SHBG levels, increasing risk of type 2 diabetes and metabolic syndrome 4
- Obesity: Major confounder in SHBG assessment, with obesity associated with lower SHBG levels 4
- Metabolic syndrome: Characterized by low SHBG levels, increasing cardiovascular disease risk 4
2. Reproductive Disorders
- Hyperandrogenism: Low SHBG levels seen in conditions with excessive androgen activity 2
- Hypogonadism: Elevated SHBG levels observed 2
- Polycystic ovary syndrome (PCOS): Characterized by low SHBG levels, contributing to increased free testosterone despite potentially normal total testosterone 4
3. Endocrine Disorders
- Thyroid dysfunction:
- Hyperthyroidism increases SHBG levels
- Hypothyroidism (myxoedema) decreases SHBG levels 2
- Hyperprolactinemia: Associated with low SHBG concentrations 2
4. Liver Disorders
- Hepatic cirrhosis: Causes elevated SHBG levels in men 2
- Liver disease: Can cause elevated SHBG, potentially masking hypogonadism by elevating total testosterone while free testosterone remains low 4
5. Cancer Risk Assessment
- Breast cancer: Altered SHBG levels associated with risk 1, 5
- Prostate cancer: SHBG levels may serve as a marker 1, 5
Physiological Variations
- Menstrual cycle: SHBG molecular forms change throughout the cycle:
- Follicular phase: 54 kD form predominates
- Periovulatory period: 90 kD isomers predominate
- Luteal phase: Both 54 kD and 90 kD forms present 6
- Menopause: Dimeric 90 kD form predominates with higher molecular forms (115-135 kD) also present 6
Factors Affecting SHBG Levels
Physiological Factors
- Sex hormones: Estrogens increase and androgens decrease SHBG production 5, 6
- Age: Levels change with aging
- Nutritional status: Low BMI/malnutrition associated with higher SHBG levels 4
Pathological Factors
- Endocrine disorders: Thyroid dysfunction, androgen disorders 5, 2
- Metabolic conditions: Obesity, insulin resistance, metabolic syndrome 4, 1
- Liver function: Hepatic diseases affect production 4, 2
Pharmacological Factors
- Medications: Androgens, estrogens, thyroid hormones, and anticonvulsants affect SHBG levels 2
- Alcohol consumption: Influences serum concentrations 5
Clinical Applications
- Evaluation of androgen disorders: Useful in assessing mild disorders of androgen metabolism 2
- Treatment guidance: Helps identify women with hirsutism more likely to respond to estrogen therapy 2
- Free hormone assessment: Testosterone:SHBG ratios correlate well with free testosterone values and help discriminate subjects with excessive androgen activity 2
- Metabolic risk assessment: Low SHBG serves as a marker for insulin resistance and metabolic syndrome 4
Measurement Considerations
- Free testosterone calculation: Should be calculated using accurate formulas that include total testosterone, SHBG, and albumin 4
- Timing: Morning measurements are preferred for testosterone assessment 4
Clinical Pitfalls to Avoid
- Relying solely on total hormone levels: Without SHBG measurement, free hormone levels cannot be accurately assessed
- Ignoring confounding factors: Obesity, liver disease, and medications can significantly alter SHBG levels, potentially masking underlying conditions 4
- Overlooking SHBG in metabolic assessment: Low SHBG is an independent risk factor for metabolic disorders and should be considered in risk stratification
SHBG remains an evolving area of research with emerging applications in clinical medicine as both a diagnostic marker and a pathophysiological mediator in various disease states 1, 5.